Synthesis and Characterization of Bioactive Glass via CTAB Modified Sol‐Gel Method for In Vitro Biological Activities
- 20 February 2025
- journal article
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 113 (3) , e35548
Abstract
Bone defect repair methods have significant drawbacks and limitations. The discovery and development of bioactive glasses (BGs) have greatly advanced the treatment of bone diseases. BGs can uniquely bond to living tissues, including bone, due to the formation of a hydroxyapatite (HAp) layer on their surface. These glasses synthesized using various catalysts and structure‐directing agents to enhance their biological activities. However, most catalysts generate toxicity, alter pH levels, and work at high concentrations. Similarly, many surfactants have limited surface areas, poor capacity to create well‐defined mesoporous structures, and potential toxicity, reducing the bioactivity, biocompatibility, and biodegradability of the BGs. To address these issues, this study evaluates a bioactive glass synthesized via the sol–gel process, using low concentration CTAB as a structure‐directing agent and citric acid as a catalyst. The phase composition, surface morphology, specific surface area, inner structure, crystal structure, elemental composition, and functional groups of the samples were characterized using X‐ray diffraction (XRD), scanning electron microscopy (SEM), Brunauer–Emmett–Teller (BET), transmission electron microscopy (TEM), selected area electron diffraction (SAED), energy‐dispersive x‐ray spectroscopy (EDS), and Fourier‐transform infrared microscopy (FTIR) techniques, respectively. The in vitro bioactivity was tested by soaking samples in simulated body fluid and analyzing the HAp layer formation using XRD, SEM, and FTIR. In addition, the in vitro biocompatibility, and an in vitro biodegradability were measured. 0.3 M of CTAB (BG3) exhibited a larger specific surface area with spherical‐shaped particles and pore volume with a mesoporous structure results better in bioactivity and biodegradability. Furthermore, all samples exhibited cell viability above 70%, indicating that the prepared materials are biocompatible. The findings highlight the potential of CTAB‐modified BGs for biomedical applications, especially in bone repair and regeneration.Keywords
This publication has 53 references indexed in Scilit:
- Bioactive Glass: Soft Tissue Reparative and Regenerative Applications2022
- Sol–Gel‐Based Advanced Porous Silica Materials for Biomedical ApplicationsAdvanced Functional Materials, 2020
- A History of Biomaterials2020
- Osteogenic potential of sol–gel bioactive glasses containing manganeseJournal of Materials Science: Materials in Medicine, 2019
- Simulated body fluid and the novel bioactive materials derived from itJournal of Biomedical Materials Research Part A, 2019
- Reprint of: Review of bioactive glass: From Hench to hybridsActa Biomaterialia, 2015
- Role of glass structure in defining the chemical dissolution behavior, bioactivity and antioxidant properties of zinc and strontium co-doped alkali-free phosphosilicate glassesActa Biomaterialia, 2014
- Bioactive glass in tissue engineeringActa Biomaterialia, 2011
- Sol–gel synthesis of bioactive glass scaffolds for tissue engineering: Effect of surfactant type and concentrationJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2005
- Calcium phosphate formation at the surface of bioactive glass in vitroJournal of Biomedical Materials Research, 1991